# Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

> **NCT02792335** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 28000 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** apixaban
- **DRUG:** dabigatran
- **DRUG:** rivaroxaban
- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT02792335
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 28000 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792335, "Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02792335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*